Publication Cover
Structural Heart
The Journal of the Heart Team
Volume 2, 2018 - Issue 4
87
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Readmission for Acute Decompensated Heart Failure among Patients Successfully Treated with Transcatheter Aortic Valve Replacement: A PARTNER-1 Substudy

, MD, MHS, , MD, , PhD, , MD, , MDORCID Icon, , MD, , MD, , MD,PhD & , MD show all
Pages 316-327 | Received 22 Jan 2018, Accepted 19 Mar 2018, Published online: 20 Apr 2018

References

  • Khazanie P, Heizer GM, Hasselblad V, et al. Predictors of clinical outcomes in acute decompensated heart failure: acute study of clinical effectiveness of nesiritide in decompensated heart failure outcome models. Am Heart J. 2015;170:290–297. doi:10.1016/j.ahj.2015.04.006
  • Fingar K, Washington R. Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013. HCUP Statistical Brief #196. https://www.ncbi.nlm.nih.gov/pubmed/26764446. 2006.
  • Ross JS, Mulvey GK, Stauffer B, et al. Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med. 2008;168:1371–1386. doi:10.1001/archinte.168.13.1371
  • Alvarez-Garcia J, Ferrero-Gregori A, Puig T, et al. A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin-SCORE. Eur J Heart Fail. 2015;17:818–827. doi:10.1002/ejhf.287
  • Fleming LM, Gavin M, Piatkowski G, Chang JD, Mukamal KJ. Derivation and validation of a 30-day heart failure readmission model. Am J Cardiol. 2014;114:1379–1382. doi:10.1016/j.amjcard.2014.07.071
  • Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433. doi:10.1161/CIRCULATIONAHA.105.584102
  • Ca E, Jg H, Km K-S, et al. Determinants of early readmission after hospitalization for heart failure. Can J Cardiol. 2014;30:612–618. doi:10.1016/j.cjca.2014.02.017
  • Khera S, Kolte D, Gupta T, et al. Association between hospital volume and 30-day readmissions following transcatheter aortic valve replacement. JAMA Cardiol. 2017;2:732–741. doi:10.1001/jamacardio.2017.1630
  • Holmes DR Jr., Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019–1028. doi:10.1001/jama.2015.1474
  • Nombela-Franco L, Del Trigo M, Morrison-Polo G, et al. Incidence, causes, and predictors of early (</=30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8:1748–1757.
  • Kolte D, Khera S, Sardar MR, et al. Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the nationwide readmissions database. Circ Cardiovasc Interv. 2017;10:e004472.
  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. doi:10.1056/NEJMoa1008232
  • Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198. doi:10.1056/NEJMoa1103510
  • Dewey TM, Bowers B, Thourani VH, et al. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg. 2013;96:2083–2089. doi:10.1016/j.athoracsur.2013.05.093
  • Fearon WF, Kodali S, Doshi D, et al. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. JACC Cardiovasc Interv. 2014;7:1245–1251. doi:10.1016/j.jcin.2014.05.033
  • Kapadia SR, Tuzcu EM, Makkar RR, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation. 2014;130:1483–1492. doi:10.1161/CIRCULATIONAHA.114.009834
  • Svensson LG, Tuzcu M, Kapadia S, et al. A comprehensive review of the PARTNER trial. J Thorac Cardiovasc Surg. 2013;145:S11–6. doi:10.1016/j.jtcvs.2012.11.051
  • Nelson W. Theory and applications of hazard plotting for censored failure data. Technometrics. 1972;14:945–966. doi:10.1080/00401706.1972.10488991
  • Nelson W. Graphical analysis of system repair data. J Qual Technol. 1988;20:24–35. doi:10.1080/00224065.1988.11979080
  • Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615–624. doi:10.1080/01621459.1986.10478314
  • Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall/CRC; 1994.
  • Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093–2109. doi:10.1002/sim.4780111607
  • Breiman L. Bagging predictors. Machine Learning. 1996;24:123–140. doi:10.1007/BF00058655
  • Rajeswaran J, Blackstone EH. Identifying risk factors: challenges of separating signal from noise. J Thorac Cardiovasc Surg. 2017;153:1136–1138. doi:10.1016/j.jtcvs.2017.01.010
  • Andersen PK, Borgan O, Gill RD, Keiding N. Chapter 4: Nonparametric Estimation. In: Statistical Models Based on Counting Processes. New York: Springer-Verlag;1993:176–331.
  • Blackstone EH, Lytle BW. Competing risks after coronary bypass surgery: the influence of death on reintervention. J Thorac Cardiovasc Surg. 2000;119:1221–1230. doi:10.1067/mtc.2000.106519
  • Rubin DB. Multiple Imputation for Non-Response in Surveys. New York: Wiley;1987.
  • Keenan PS, Normand SL, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1:29–37. doi:10.1161/CIRCOUTCOMES.108.802686
  • Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581–2587. doi:10.1001/jama.290.19.2581
  • O’Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). Am Heart J. 2008;156:662–673. doi:10.1016/j.ahj.2008.04.030
  • Felker GM, Leimberger JD, Califf RM, et al. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004;10:460–466. doi:10.1016/j.cardfail.2004.02.011
  • Okazaki H, Shirakabe A, Hata N, et al. New scoring system (APACHE-HF) for predicting adverse outcomes in patients with acute heart failure: evaluation of the APACHE II and Modified APACHE II scoring systems. J Cardiol. 2014;64:441–449. doi:10.1016/j.jjcc.2014.03.002
  • Scrutinio D, Ammirati E, Guida P, et al. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score. Int J Cardiol. 2013;168:2120–2126. doi:10.1016/j.ijcard.2013.01.005
  • Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62:e147–239. doi:10.1016/j.jacc.2013.05.019
  • Haneuse S, Lee KH. Semi-competing risks data analysis: accounting for death as a competing risk when the outcome of interest is nonterminal. Circ Cardiovasc Qual Outcomes. 2016;9:322–331. doi:10.1161/CIRCOUTCOMES.115.001841
  • Barbanti M, Webb JG, Hahn RT, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the placement of aortic transcatheter valve (PARTNER) trial cohort A. Circulation. 2013;128:2776–2784. doi:10.1161/CIRCULATIONAHA.113.003885
  • Genereux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–1136. doi:10.1016/j.jacc.2012.08.1039
  • Lindman BR, Stewart WJ, Pibarot P, et al. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. JACC Cardiovasc Interv. 2014;7:662–673. doi:10.1016/j.jcin.2014.02.011
  • Rudolph V, Schirmer J, Franzen O, et al. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. Int J Cardiol. 2013;167:716–720. doi:10.1016/j.ijcard.2012.03.060
  • Page RL 2nd, O’Bryant CL, Cheng D, et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134:e32–69. doi:10.1161/CIR.0000000000000426
  • Helder MR, Ugur M, Bavaria JE, et al. The effect of postoperative medical treatment on left ventricular mass regression after aortic valve replacement. J Thorac Cardiovasc Surg. 2015;149:781–786. doi:10.1016/j.jtcvs.2014.10.034
  • Claveau D, Piha-Gossack A, Friedland SN, Afilalo J, Rudski L. Complications associated with nitrate use in patients presenting with acute pulmonary edema and concomitant moderate or severe aortic stenosis. Ann Emerg Med. 2015;66:355–62 e1. doi:10.1016/j.annemergmed.2015.03.027
  • Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Statist. 2008;2:841–860. doi:10.1214/08-AOAS169
  • Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Statist. 2000;29:1189–1232. doi:10.1214/aos/1013203451

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.